(Corrects date of review to April 30, not Monday, following
correction from WHO spokesman)
GENEVA, April 26 (Reuters) - Moderna's COVID-19
vaccine is being reviewed on April 30 by technical experts for
possible WHO emergency use listing, a World Health Organization
spokesman told Reuters.
"We are discussing the Moderna COVID-19 vaccine on Friday 30
April 2021,” WHO spokesman Christian Lindmeier said in reply to
a query. A decision on the U.S. drugmaker's vaccine was expected
in one to four days after that, he said.
So far COVID-19 vaccines made by Pfizer, AstraZeneca
and Johnson & Johnson have already received WHO
approval, which is a signal to national regulatory authorities
on a product's safety and efficacy.
(Reporting by Stephanie Nebehay; editing by Emma Farge)
Astrazeneca (AZN)
